How ADHD is actually diagnosed
One of the biggest misconceptions about ADHD is that there is a fast test that gives a simple yes-or-no answer. There is not. ADHD is a process with several steps, there is no single test, and other conditions—such as sleep disorders, anxiety, depression, and some learning problems—can look similar. Symptoms in adults may look different than they do in children.
A real evaluation should look at more than difficulty focusing. It should include:
- what symptoms you are having now
- how long they have been affecting work, school, or daily life
- whether symptoms were present earlier in life
- whether they show up in more than one setting
- whether another condition could explain them better
That is one reason we do not frame ADHD care as a prescription question first. Good care starts with a careful evaluation, not with an assumption.
Treatment is bigger than stimulant access
ADHD treatment is not limited to one medication category. CDC states that treatment for adults can include medication, psychotherapy, education or training, or a combination of treatments. NIMH similarly describes standard ADHD treatment as including medication plus psychosocial interventions.
This matters because patients often end up searching only for stimulant access when what they may actually need is a broader plan:
- a proper evaluation
- skills or behavioral support
- a medication review
- treatment for coexisting anxiety, depression, or sleep issues
- referral when specialist care makes more sense
We think that is the more honest way to talk about ADHD care. Medication may be part of treatment, but it is not the whole treatment plan.
Why stimulant access is still such a common problem
Medication access remains a real issue for many patients with ADHD. CDC reported that in 2023, about one third of adults with current ADHD took a stimulant medication in the previous year, and 71.5% of those patients reported difficulty getting their prescription filled because the medication was unavailable. The same CDC report found that about half of adults with ADHD have used telehealth for ADHD-related care.
Current shortage bulletins also show why patients keep running into delays. ASHP’s active shortage updates continue to list availability issues affecting multiple amphetamine and methylphenidate products, with some manufacturers reporting back orders, allocations, manufacturing delays, or increased demand.
That is why patients often feel stuck between two problems:
- getting the right evaluation and treatment plan
- getting reliable access to the treatment they have already been prescribed
Why “just find it somewhere else” is not a safe plan
When ADHD medication access is disrupted, patients can be tempted to borrow medication, ration doses without medical guidance, buy pills online, or accept pills from friends or relatives. That is exactly where risk increases.
FDA has strengthened warnings on prescription stimulants because of serious risks involving misuse, abuse, addiction, overdose, and sharing these medications. FDA also warns that sharing prescription stimulants can contribute to substance use disorder and addiction in the person receiving them.
CDC issued a Health Alert Network advisory in 2024 warning that disrupted access to prescription stimulant medications could increase the risk of injury and overdose. CDC specifically warned patients to avoid medication obtained from anyone other than a licensed clinician and licensed pharmacy, noting the risk of counterfeit pills in the illegal market.
So if your medication is hard to find, the safest next move is not to improvise. It is to work through licensed, legal channels.
What current telehealth rules mean for ADHD medication
This is the part many patients find confusing because the answer is both simple and nuanced.
The simple version: some authorized, DEA-registered practitioners may prescribe controlled substances through telehealth if required conditions are met, and the current federal telemedicine flexibilities have been extended through December 31, 2026.
The nuance: that does not mean every telehealth company, every clinician, or every platform provides stimulant prescribing. Provider licensure, federal law, state law, platform policies, and clinical judgment all matter. And at MyerleeMD, we are transparent about our own scope: we do not prescribe DEA-controlled substances through our platform.
For patients, that honesty is useful. It saves time, reduces false expectations, and helps you choose the right care setting sooner.
What to do if your ADHD medication is hard to get
If you already have a diagnosis and your medication is suddenly difficult to fill, do not wait until you are out completely to start making calls. Availability can vary by dose, formulation, and manufacturer, and the situation may change from week to week.
A safer approach looks like this:
1. Contact your prescribing clinician early
Let them know the exact medication, dose, and formulation that is unavailable. Do not change products or dosing on your own.
2. Call your pharmacy before pickup
Ask whether the medication is in stock, on back order, or only delayed for a specific strength or manufacturer. Shortage bulletins show that these details matter.
3. Do not borrow, share, or buy pills outside licensed care
FDA and CDC have both warned about the risks of misuse, diversion, and counterfeit pills.
4. Ask your clinician whether another lawful, appropriate option exists
That may mean a different product, a different formulation, a non-stimulant approach, or a temporary change in the plan. The key is that the decision belongs to your prescribing clinician, not to guesswork.
5. Dispose of unused medication safely if your plan changes
Unused medication should be stored safely and disposed of properly when appropriate. Myerlee Pharmacy also maintains local medication-disposal information for Lee County patients.
How we help patients navigate the next step
At MyerleeMD, we believe telehealth is most valuable when it removes confusion—not when it creates it. Telehealth works well for private conversations, medication reviews, follow-up planning, and helping patients figure out whether virtual care, in-person care, or specialist care is the right fit. We also use telehealth because it can make follow-up easier, reduce friction, and support better continuity of care when ongoing management matters.
That means our role in ADHD-related questions is not to promise stimulant access. Our role is to help patients:
- understand whether their symptoms need fuller evaluation
- sort out medication-access questions safely
- identify when specialist or in-person ADHD care is the better path
- avoid unsafe shortcuts when treatment is disrupted
Our pharmacy team can also support the follow-through side of care. Myerlee Pharmacy offers prescription refill services, general prescription-transfer support, free local delivery on designated schedules, and local medication-disposal resources. We do not recommend assuming that every ADHD prescription can be transferred in the same way, because controlled-substance rules can be more complex, but our team can still help patients understand practical next steps and coordinate within the rules that apply.
Frequently asked questions
Can ADHD be diagnosed through telehealth?
An evaluation may begin through telehealth, but ADHD diagnosis is a multi-step process. CDC says there is no single ADHD test, and other conditions can look similar.
Can telehealth prescribe stimulant medication?
Some DEA-registered providers may prescribe controlled substances through telehealth if legal and clinical requirements are met, and current federal flexibilities run through December 31, 2026. But not every provider or platform offers that service. At MyerleeMD, we do not prescribe DEA-controlled substances.
Are stimulants the only treatment for ADHD?
No. CDC and NIMH both describe ADHD treatment as potentially including medication, psychotherapy, education or training, and other psychosocial interventions.
What should I do if my stimulant is out of stock?
Contact your prescribing clinician and pharmacy early, confirm the exact product shortage, and do not substitute, borrow, or buy medication outside licensed channels.
Is it safe to use someone else’s ADHD medication?
No. FDA warns that sharing prescription stimulants carries serious risks, including misuse, addiction, and overdose.
Final thoughts
ADHD care is complicated enough without mixed messages about telehealth and stimulant access. The safest approach is to separate three questions clearly:
- Do these symptoms actually fit ADHD?
- What kind of treatment plan is appropriate?
- What care setting is legally and clinically right for that plan?
At MyerleeMD, we believe patients deserve direct answers. Telehealth can be a useful starting point for symptom review, next-step planning, and medication-related questions—but it is not the right tool for every diagnosis or every prescription pathway. If you are dealing with ADHD-related concerns and want help understanding the safest next step, start with a confidential conversation and let us help you decide what kind of care makes the most sense.